The Circadian Clock in Cancer Development and Therapy - Progress in Molecular Biology and Translational Science - page 261

27. Davidson AJ, Castanon-Cervantes O, Leise TL, Molyneux PC, Harrington ME. Visu-
alizing jet lag in the mouse suprachiasmatic nucleus and peripheral circadian timing
system. Eur J Neurosci . 2009;29(1):171-180.
28. Kennaway DJ, Owens JA, Voultsios A, Varcoe TJ. Functional central rhythmicity and
light entrainment, but not liver and muscle rhythmicity, are Clock independent. Am
J Physiol Regul Integr Comp Physiol . 2006;291(4):R1172-R1180.
29. Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. Disrupting circadian homeostasis
of sympathetic signaling promotes tumor development in mice. PLoS One . 2010;5(6):
e10995.
30. Barclay JL, Tsang AH, Oster H. Interaction of central and peripheral clocks in phys-
iological regulation. Prog Brain Res . 2012;199:163-181.
31. Balsalobre A, Brown SA, Marcacci L, et al. Resetting of circadian time in peripheral
tissues by glucocorticoid signaling. Science . 2000;289(5488):2344-2347.
32. Richter HG, Torres-Farfan C, Rojas-Garcia PP, Campino C, Torrealba F, Seron-
Ferre M. The circadian timing system: making sense of day/night gene expression. Biol
Res . 2004;37(1):11-28.
33. Kalsbeek A, Bruinstroop E, Yi CX, Klieverik LP, La Fleur SE, Fliers E. Hypothalamic
control of energy metabolism via the autonomic nervous system. Ann N Y Acad Sci .
2010;1212:114-129.
34. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal
cancer in the nurses' health study. J Natl Cancer Inst . 2003;95(11):825-828.
35. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate can-
cer among rotating-shift workers: findings from the Japan collaborative cohort study.
Am J Epidemiol . 2006;164(6):549-555.
36. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of
endometrial cancer. Cancer Res . 2007;67(21):10618-10622.
37. Lahti TA, Partonen T, Kyyronen P, Kauppinen T, Pukkala E. Night-time work
predisposes to non-Hodgkin lymphoma. Int J Cancer . 2008;123(9):2148-2151.
38. Stevens RG. Working against our endogenous circadian clock: breast cancer and
electric lighting in the modern world. Mutat Res . 2009;680(1-2):106-108.
39. Touitou Y, Bogdan A, Levi F, Benavides M, Auzeby A. Disruption of the circadian
patterns of serum cortisol in breast and ovarian cancer patients: relationships with
tumour marker antigens. Br J Cancer . 1996;74(8):1248-1252.
40. Panzer A. Melatonin in osteosarcoma: an effective drug? Med Hypotheses . 1997;48
(6):523-525.
41. Skibola CF, Holly EA, Forrest MS, et al. Body mass index, leptin and leptin receptor
polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev .
2004;13(5):779-786.
42. Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and
endometrial cancer in women. Cancer Lett . 2009;281(1):1-7.
43. Kloog I, Haim A, Stevens RG, Portnov BA. Global co-distribution of light at night
(LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int . 2009;26
(1):108-125.
44. Knutsson A, Alfredsson L, Karlsson B, et al. Breast cancer among shift workers:
results of the WOLF longitudinal cohort study. Scand J Work Environ Health . 2013;
39(2):170-177.
45. Bhatti P, Mirick DK, Davis S. Invited commentary: shift work and cancer. Am
J Epidemiol . 2012;176(9):760-763, discussion 764-765.
46. Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of
circadian disruption, light at night, and sleep deprivation. Sleep Med Rev . 2013;

17(4):273-284.
47. Buzzelli G, Dattolo P, Pinzani M, Brocchi A, Romano S, Gentilini P. Circulating
growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with